Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Enovis (ENOV) EBT (2016 - 2026)

Enovis has reported EBT over the past 16 years, most recently at -$509.5 million for Q4 2025.

  • Quarterly EBT rose 24.37% to -$509.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Dec 2025, down 40.89% year-over-year, with the annual reading at -$1.2 billion for FY2025, 40.89% down from the prior year.
  • EBT was -$509.5 million for Q4 2025 at Enovis, up from -$566.9 million in the prior quarter.
  • Over five years, EBT peaked at $116.4 million in Q3 2022 and troughed at -$673.7 million in Q4 2024.
  • The 5-year median for EBT is -$28.7 million (2023), against an average of -$105.3 million.
  • Year-over-year, EBT soared 401.46% in 2023 and then crashed 8898.82% in 2024.
  • A 5-year view of EBT shows it stood at -$24.6 million in 2021, then soared by 89.67% to -$2.5 million in 2022, then soared by 401.46% to $7.7 million in 2023, then crashed by 8898.82% to -$673.7 million in 2024, then grew by 24.37% to -$509.5 million in 2025.
  • Per Business Quant, the three most recent readings for ENOV's EBT are -$509.5 million (Q4 2025), -$566.9 million (Q4 2025), and -$25.7 million (Q3 2025).